Relmada Therapeutics (RLMD) Shares Issued (2014 - 2026)

Relmada Therapeutics (RLMD) has 12 years of Shares Issued data on file, last reported at $10.8 million in Q1 2026.

• On a quarterly basis, Shares Issued rose 3498.93% year-over-year to $10.8 million in Q1 2026; TTM through Mar 2026 was $10.8 million, a 3498.93% increase from a year earlier, with the FY2025 full-year figure at $5.4 million, down 55.69% from the prior year.
• Shares Issued for Q1 2026 stood at $10.8 million, up from $5.4 million in the prior quarter.
• Over the last five years, Shares Issued for RLMD reached as high as $17.4 million in Q4 2023 and fell as low as $17886.0 in Q2 2022.
• Historically, Shares Issued has averaged $7.9 million across 5 years, with a median of $8.9 million in 2024.
• Across the five-year window, Shares Issued slumped 99.65% in 2022 and soared 31220.44% in 2023, its largest moves.
• Year by year, Shares Issued stood at $12.1 million in 2022, then jumped by 43.67% to $17.4 million in 2023, then decreased by 29.59% to $12.3 million in 2024, then sank by 55.69% to $5.4 million in 2025, then jumped by 98.68% to $10.8 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $10.8 million in Q1 2026, $5.4 million in Q4 2025, and $775000.0 in Q3 2025.